VBI Vaccines to Participate in the 2018 Oppenheimer Boston Oncology Insight Summit
July 09 2018 - 8:00AM
VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”), a commercial-stage
biopharmaceutical company developing next-generation infectious
disease and immuno-oncology vaccines, today announced that the
company will participate in the Oppenheimer Boston Oncology Insight
Summit July 10 – 11, 2018. The two-day summit will feature a series
of discussions with primary investigators at the Whitehead
Institute in Cambridge, Massachusetts, followed by one-on-one
meetings with institutional investors at the Four Seasons Hotel in
Boston, Massachusetts.
To learn more about the event, please visit the following link:
https://www.opco.com/conferences/oncology18/index.aspx.
About VBI Vaccines Inc.
VBI Vaccines Inc. (“VBI”) is a commercial-stage
biopharmaceutical company developing a next generation of vaccines
to address unmet needs in infectious disease and immuno-oncology.
VBI’s first marketed product is Sci-B-Vac®, a
hepatitis B (HBV) vaccine that mimics all three viral surface
antigens of the hepatitis B virus; Sci-B-Vac® is
approved for use in Israel and 14 other countries. VBI’s eVLP
Platform technology allows for the development of enveloped
virus-like particle (eVLP) vaccines that closely mimic the target
virus to elicit a potent immune response. VBI is advancing a
pipeline of eVLP vaccines, with lead programs in cytomegalovirus
(CMV) and glioblastoma (GBM). VBI is headquartered in Cambridge, MA
with research operations in Ottawa, Canada and research and
manufacturing facilities in Rehovot, Israel.
- Website Home: http://www.vbivaccines.com/
- News and Insights: http://www.vbivaccines.com/wire/
- Investors: http://www.vbivaccines.com/investors/
VBI Contact
Nicole Anderson, Communications ExecutivePhone: (617) 830-3031
x124Email: info@vbivaccines.com
VBI Investor Contact
Nell BeattieChief Business OfficerEmail: IR@vbivaccines.com
VBI Media Contact
Justin JacksonBurns McClellan, Inc.Phone: (212) 213-0006Email:
jjackson@burnsmc.com
VBI Vaccines (NASDAQ:VBIV)
Historical Stock Chart
From Apr 2024 to May 2024
VBI Vaccines (NASDAQ:VBIV)
Historical Stock Chart
From May 2023 to May 2024